Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-15

Clinical Trial Update: Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating psilocybin-assisted psychotherapy for adults with Alcohol Use Disorder, sponsored by Clairvoyant Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Clairvoyant Therapeutics | Conditions: Alcohol Use Disorder | Phase 2 | Status: UNKNOWN